Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10273233 Inhibitors of influenza viruses replication

Patent 10273233 was granted and assigned to Vertex Pharmaceuticals on April, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 9 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 9 Dec, 2023
Edits made to:
Article (+168 characters)
Article

Patent abstract

Polymorphic forms of Compound (1) or a pharmaceutically acceptable salt thereof, wherein Compound (1) is represented by the following structural formula:

Edits on 2 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 2 Oct, 2023
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Dean Shannon0
Kwame W. Nti-Addae0
Luc J. Farmer0
Michael John Boyd0
Michael Waldo0
Yuegang Zhang0
Edits on 22 Jul, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 22 Jul, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=102732330
Edits on 28 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Apr, 2023
Edits on 7 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 7 Apr, 2023
Edits on 24 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Mar, 2023
Infobox
Patent Citations Received
‌
US Patent 10801077 Influenza A virus variants
0
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Edits on 24 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Edits on 22 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Sep, 2022
Infobox
Patent Citations Received
‌
US Patent 10801077 Influenza A virus variants
0
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Sep, 2022
Edits on 18 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 18 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10273233
Edits on 8 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 8 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10875855 Inhibitors of influenza viruses replication
Edits on 7 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10801077 Influenza A virus variants
Edits on 31 Jan, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 31 Jan, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10533004 Methods of preparing inhibitors of influenza viruses replication
Edits on 26 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 26 Jan, 2022
Edits made to:
Infobox (+10 properties)
‌

 US Patent 10273233 Inhibitors of influenza viruses replication

Infobox
Is a
Patent
Patent
Patent applicant
Vertex Pharmaceuticals
Vertex Pharmaceuticals
Current assignee
Vertex Pharmaceuticals
Vertex Pharmaceuticals
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10273233
Date of patent
April 30, 2019
Patent application number
15807984
Date Filed
November 9, 2017
Patent citations
‌
US Patent 10039762 Inhibitors of influenza viruses replication
Patent primary examiner
‌
Charanjit Aulakh

Find more entities like US Patent 10273233 Inhibitors of influenza viruses replication

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.